AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea · Delayed Price · Currency is KRW 8,250.00
-30.00 (-0.36%)
Aug 13, 2025, 3:30 PM KST
Heartland Financial USA Market Cap
AptaBio Therapeutics has a market cap or net worth of 221.77 billion as of August 13, 2025. Its market cap has decreased by -31.27% in one year.
Market Cap
221.77B
Enterprise Value
204.82B
Revenue
3.11B
Ranking
n/a
PE Ratio
n/a
Stock Price
$8,250.00
Market Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 221.77B, a decrease of -47.61%. That is a compound annual growth rate of -9.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 222.58B | 29.98% |
| Dec 30, 2024 | 171.23B | -15.15% |
| Dec 28, 2023 | 201.80B | -15.02% |
| Dec 29, 2022 | 237.48B | -71.24% |
| Dec 30, 2021 | 825.71B | 46.50% |
| Dec 30, 2020 | 563.64B | 49.70% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.45T |
| Celltrion | 38.14T |
| ALTEOGEN | 22.98T |
| Yuhan | 8,383.50B |
| SK Biopharmaceuticals | 7,737.35B |
| PharmaResearch | 7,064.96B |
| Peptron | 6,989.21B |
| LigaChem Biosciences | 5,419.69B |